Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles

Abstract The pure alpha emitter 148Gd may have a significant radiological impact in terms of internal dose to exposed humans in case of accidental releases from a spallation source using a tungsten target, such as the one to be used in the European Spallation Source (ESS). In this work we aim to pre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: C. Rääf, V. Barkauskas, K. Eriksson Stenström, C. Bernhardsson, H. B. L. Pettersson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e955f6be289c4df3a665a026078552a7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e955f6be289c4df3a665a026078552a7
record_format dspace
spelling oai:doaj.org-article:e955f6be289c4df3a665a026078552a72021-12-02T13:58:13ZInternal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles10.1038/s41598-020-77718-32045-2322https://doaj.org/article/e955f6be289c4df3a665a026078552a72020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77718-3https://doaj.org/toc/2045-2322Abstract The pure alpha emitter 148Gd may have a significant radiological impact in terms of internal dose to exposed humans in case of accidental releases from a spallation source using a tungsten target, such as the one to be used in the European Spallation Source (ESS). In this work we aim to present an approach to indirectly estimate the whole-body burden of 148Gd and the associated committed effective dose in exposed humans, by means of high-resolution gamma spectrometry of the gamma-emitting radiogadolinium isotopes 146Gd and 153Gd that are accompanied by 148Gd generated from the operation of the tungsten target. Theoretical minimum detectable whole-body activity (MDA) and associated internal doses from 148Gd are calculated using a combination of existing biokinetic models and recent computer simulation studies on the generated isotope ratios of 146Gd/148Gd and 153Gd/148Gd in the ESS target. Of the two gamma-emitting gadolinium isotopes, 146Gd is initially the most sensitive indicator of the presence of 148Gd if whole-body counting is performed within a month after the release, using the twin photo peaks of 146Gd centered at 115.4 keV (MDA < 1 Bq for ingested 148Gd, and < 25 Bq for inhaled 148Gd). The corresponding minimum detectable committed effective doses will be less than 1 µSv for ingested 148Gd, but substantially higher for inhaled 148Gd (up to 0.3 mSv), depending on operation time of the target prior to the release. However, a few months after an atmospheric release, 153Gd becomes a much more sensitive indicator of body burdens of 148Gd, with a minimum detectable committed effective doses ranging from 18 to 77 µSv for chronic ingestion and between 0.65 to 2.7 mSv for acute inhalation in connection to the release. The main issue with this indirect method for 148Gd internal dose estimation, is whether the primary photon peaks from 146 and 153Gd can be detected undisturbed. Preliminary simulations show that nuclides such as 182Ta may potentially create perturbations that could impair this evaluation method, and which impact needs to be further studied in future safety assessments of accidental target releases.C. RääfV. BarkauskasK. Eriksson StenströmC. BernhardssonH. B. L. PetterssonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
C. Rääf
V. Barkauskas
K. Eriksson Stenström
C. Bernhardsson
H. B. L. Pettersson
Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles
description Abstract The pure alpha emitter 148Gd may have a significant radiological impact in terms of internal dose to exposed humans in case of accidental releases from a spallation source using a tungsten target, such as the one to be used in the European Spallation Source (ESS). In this work we aim to present an approach to indirectly estimate the whole-body burden of 148Gd and the associated committed effective dose in exposed humans, by means of high-resolution gamma spectrometry of the gamma-emitting radiogadolinium isotopes 146Gd and 153Gd that are accompanied by 148Gd generated from the operation of the tungsten target. Theoretical minimum detectable whole-body activity (MDA) and associated internal doses from 148Gd are calculated using a combination of existing biokinetic models and recent computer simulation studies on the generated isotope ratios of 146Gd/148Gd and 153Gd/148Gd in the ESS target. Of the two gamma-emitting gadolinium isotopes, 146Gd is initially the most sensitive indicator of the presence of 148Gd if whole-body counting is performed within a month after the release, using the twin photo peaks of 146Gd centered at 115.4 keV (MDA < 1 Bq for ingested 148Gd, and < 25 Bq for inhaled 148Gd). The corresponding minimum detectable committed effective doses will be less than 1 µSv for ingested 148Gd, but substantially higher for inhaled 148Gd (up to 0.3 mSv), depending on operation time of the target prior to the release. However, a few months after an atmospheric release, 153Gd becomes a much more sensitive indicator of body burdens of 148Gd, with a minimum detectable committed effective doses ranging from 18 to 77 µSv for chronic ingestion and between 0.65 to 2.7 mSv for acute inhalation in connection to the release. The main issue with this indirect method for 148Gd internal dose estimation, is whether the primary photon peaks from 146 and 153Gd can be detected undisturbed. Preliminary simulations show that nuclides such as 182Ta may potentially create perturbations that could impair this evaluation method, and which impact needs to be further studied in future safety assessments of accidental target releases.
format article
author C. Rääf
V. Barkauskas
K. Eriksson Stenström
C. Bernhardsson
H. B. L. Pettersson
author_facet C. Rääf
V. Barkauskas
K. Eriksson Stenström
C. Bernhardsson
H. B. L. Pettersson
author_sort C. Rääf
title Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles
title_short Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles
title_full Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles
title_fullStr Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles
title_full_unstemmed Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles
title_sort internal dose assessment of 148gd using isotope ratios of gamma-emitting 146gd or 153gd in accidently released spallation target particles
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/e955f6be289c4df3a665a026078552a7
work_keys_str_mv AT craaf internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
AT vbarkauskas internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
AT kerikssonstenstrom internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
AT cbernhardsson internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
AT hblpettersson internaldoseassessmentof148gdusingisotoperatiosofgammaemitting146gdor153gdinaccidentlyreleasedspallationtargetparticles
_version_ 1718392235081334784